BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2900827)

  • 21. Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma.
    Rothberg PG; Spandorfer JM; Erisman MD; Staroscik RN; Sears HF; Petersen RO; Astrin SM
    Br J Cancer; 1985 Oct; 52(4):629-32. PubMed ID: 4063140
    [No Abstract]   [Full Text] [Related]  

  • 22. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer.
    Jiang Q; Chen K; Ma X; Li Q; Yu W; Shu G; Yao K
    Cancer Detect Prev; 2005; 29(2):146-54. PubMed ID: 15829374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [KRAS gene mutation in colorectal cancer].
    Roa I; Sánchez T; Majlis A; Schalper K
    Rev Med Chil; 2013 Sep; 141(9):1166-72. PubMed ID: 24522420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation study of allelic gene deletion of nm23-H1 and human colorectal carcinoma metastasis].
    Xu W; Bai J; Yang D
    Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):263-5. PubMed ID: 7587891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased frequency of the S-allele of the L-myc oncogene in breast cancer.
    Isbir T; Yaylim I; Arîkan S; Küçücük S; Camlíca H
    Mol Med; 2002 Sep; 8(9):521-4. PubMed ID: 12456990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial colorectal cancer.
    Thomas HJ
    BMJ; 1993 Jul; 307(6899):277-8. PubMed ID: 8397026
    [No Abstract]   [Full Text] [Related]  

  • 27. Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in genitourinary cancers.
    Kakehi Y; Taki Y; Yoshida O
    Urol Int; 1991; 47 Suppl 1():86-9. PubMed ID: 1683040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetic polymorphism and susceptibility to cancer].
    Larsen CJ
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):39-43. PubMed ID: 2898751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic abnormalities in colorectal cancer].
    Salmon RJ; Girodet J; Remvikos Y; Muleris M; Olschwang S; Thomas G
    Ann Gastroenterol Hepatol (Paris); 1995; 31(1):23-7. PubMed ID: 7710247
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic polymorphisms of glutathione S-transferase genes and susceptibility to colorectal cancer: a case-control study in an Indian population.
    Wang J; Jiang J; Zhao Y; Gajalakshmi V; Kuriki K; Suzuki S; Nagaya T; Nakamura S; Akasaka S; Ishikawa H; Tokudome S
    Cancer Epidemiol; 2011 Feb; 35(1):66-72. PubMed ID: 20688591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oncogenes and tumor suppressor genes in the development of colonic tumors].
    Maeda Y; Miyaki M
    Nihon Naika Gakkai Zasshi; 1992 May; 81(5):643-8. PubMed ID: 1355100
    [No Abstract]   [Full Text] [Related]  

  • 32. Activated N-ras in a human rectal carcinoma cell line associated with clonal homozygosity in myb locus-restriction fragment polymorphism.
    Yuasa Y; Reddy EP; Rhim JS; Tronick SR; Aaronson SA
    Jpn J Cancer Res; 1986 Jul; 77(7):639-47. PubMed ID: 3017909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a frequent polymorphism in the coding sequence of the Tp53 gene in colonic cancer patients and a control population.
    Olschwang S; Laurent-Puig P; Vassal A; Salmon RJ; Thomas G
    Hum Genet; 1991 Feb; 86(4):369-70. PubMed ID: 1999338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent study on colorectal cancer in China: early detection and novel related gene.
    Zheng S
    Chin Med J (Engl); 1997 Apr; 110(4):309-10. PubMed ID: 9594234
    [No Abstract]   [Full Text] [Related]  

  • 35. [A comparative study on p53 gene mutation in primary human Dukes C colon cancer with that in matched lymph node metastasis].
    Zhang J; Caplin S; Benhattar J
    Zhonghua Bing Li Xue Za Zhi; 1997 Apr; 26(2):85-8. PubMed ID: 10072877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosome 5 allele loss in human colorectal carcinomas.
    Solomon E; Voss R; Hall V; Bodmer WF; Jass JR; Jeffreys AJ; Lucibello FC; Patel I; Rider SH
    Nature; 1987 Aug 13-19; 328(6131):616-9. PubMed ID: 2886919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miRNAs in colon and rectal cancer: A consensus for their true clinical value.
    Agostini M; Pucciarelli S; Calore F; Bedin C; Enzo M; Nitti D
    Clin Chim Acta; 2010 Sep; 411(17-18):1181-6. PubMed ID: 20452339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer: molecular genetic studies and their future clinical applications.
    Fearon ER
    Med Pediatr Oncol Suppl; 1996; 1():35-40. PubMed ID: 8643046
    [No Abstract]   [Full Text] [Related]  

  • 39. L-myc gene polymorphism and risk of thyroid cancer.
    Yaylim-Eraltan I; Bozkurt N; Ergen A; Zeybek U; Ozturk O; Arikan S; Erbil Y; Uslu I; Camlica H; Isbir T
    Exp Oncol; 2008 Jun; 30(2):117-20. PubMed ID: 18566574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Eco RI restriction length polymorphism at the murine L-myc locus.
    Dolcetti R; Rizzo S; Pistello M; Boiocchi M
    Nucleic Acids Res; 1988 Dec; 16(24):11853. PubMed ID: 2905449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.